About Invitae
Invitae is a company based in San Francisco (United States) founded in 2010 by Michele Cargill and Sean Emerson George.. Invitae has raised $189.56 million across 11 funding rounds from investors including SoftBank Group, Orbimed and Farallon Capital Management. The company has 1,700 employees as of December 31, 2022. Invitae has completed 13 acquisitions, including AltaVoice, ArcherDX and CancerGene Connect. Invitae offers products and services including Oncology Tests, Women's Health Tests, Pediatrics and Rare Diseases Tests, Cardiology Tests, and Neurology Tests. Invitae operates in a competitive market with competitors including Everlywell, Viome, Color, Strand Life Sciences and Genome Medical, among others.
- Headquarter San Francisco, United States
- Employees 1700 as on 31 Dec, 2022
- Founders Michele Cargill, Sean Emerson George
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$516.3 M12as on Dec 31, 2022
-
Net Profit
$-3.11 B-720as on Dec 31, 2022
-
EBITDA
$-3.12 B-696as on Dec 31, 2022
-
Total Equity Funding
$189.56 M (USD)
in 11 rounds
-
Latest Funding Round
$1.15 B (USD), Post-IPO
Apr 05, 2021
-
Investors
SoftBank Group
& 16 more
-
Employee Count
1700
as on Dec 31, 2022
-
Investments & Acquisitions
AltaVoice
& 12 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Invitae
Invitae offers a comprehensive portfolio of products and services, including Oncology Tests, Women's Health Tests, Pediatrics and Rare Diseases Tests, Cardiology Tests, and Neurology Tests. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Genetic tests for cancer risks and diagnostics
Tests for genetic factors in women's health issues
Services for identifying rare genetic conditions in children
Genetic analysis for heart-related conditions
Tests for neurological disorder genetic risks
Unlock access to complete
Unlock access to complete
Software Development Team
172 people
Leadership Team
143 people
Sales and Marketing
52 people
Product Management Team
38 people
Human Resources and Administration
36 people
Operations Team
33 people
Data Analysis and Operations Team
32 people
Senior Team
29 people
Unlock access to complete
Funding Insights of Invitae
Invitae has successfully raised a total of $189.56M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.15 billion completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Post-IPO — $1.1B
-
First Round
First Round
(07 Nov 2012)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Post-IPO - Invitae | Valuation |
investors |
|
| Jul, 2020 | Amount | Post-IPO - Invitae | Valuation |
investors |
|
| Sep, 2019 | Amount | Post-IPO - Invitae | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Invitae
Invitae has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include SoftBank Group, Orbimed and Farallon Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple investment strategies are pursued by this hedge fund.
|
Founded Year | Domain | Location | |
|
Structured financing solutions are provided for the global healthcare industry by Oberland Capital.
|
Founded Year | Domain | Location | |
|
Venture debt firm focused on the life sciences sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Invitae
Invitae has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include AltaVoice, ArcherDX and CancerGene Connect. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Personal health data is stored, managed, and shared online.
|
2017 | ||||
|
Chatbot and telemedicine platform for genetic results interpretation is provided.
|
2016 | ||||
|
Provider of technical support services for biopharma industry
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Invitae
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Invitae Comparisons
Competitors of Invitae
Invitae operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Everlywell, Viome, Color, Strand Life Sciences and Genome Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
At-home health tests for biomarkers, nutrition, and hormone analysis.
|
|
| domain | founded_year | HQ Location |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Genomic testing services are provided clinically and directly to consumers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Invitae
Frequently Asked Questions about Invitae
When was Invitae founded?
Invitae was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Where is Invitae located?
Invitae is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Invitae?
Sean Emerson George is the current CEO of Invitae. They have also founded this company.
Is Invitae a funded company?
Invitae is a funded company, having raised a total of $189.56M across 11 funding rounds to date. The company's 1st funding round was a Post-IPO of $350M, raised on Nov 07, 2012.
How many employees does Invitae have?
As of Dec 31, 2022, the latest employee count at Invitae is 1,700.
What is the annual revenue of Invitae?
Annual revenue of Invitae is $516.3M as on Dec 31, 2022.
What does Invitae do?
Invitae was founded in 2010 in San Francisco, United States, and operates in the genetic testing sector. Genetic tests are requested online by individuals, with saliva samples collected through assistance from doctors. Diseases are detected via analysis, and results are accessed online for sharing with healthcare providers. The platform supports home-based services focused on personal genetic health assessments.
Who are the top competitors of Invitae?
Invitae's top competitors include Strand Life Sciences, Viome and Fulgent Genetics.
What products or services does Invitae offer?
Invitae offers Oncology Tests, Women's Health Tests, Pediatrics and Rare Diseases Tests, Cardiology Tests, and Neurology Tests.
How many acquisitions has Invitae made?
Invitae has made 13 acquisitions, including AltaVoice, ArcherDX, and CancerGene Connect.
Who are Invitae's investors?
Invitae has 17 investors. Key investors include SoftBank Group, Orbimed, Farallon Capital Management, Driehaus, and Oxford Finance.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.